Asosiy kontentga oʻtish
AkademScholar

Kashfiyot

Xizmatlar

Identifikatsiya

Ishlab chiquvchilar uchun

Ekotizim

Muassasalar

Oregon Health & Science University

Nom variantlari: OHSU · Oregon Health Sciences University · University of Oregon Health Sciences Center

Davlat:
US
ROR:
https://ror.org/009avj582
7
h-indeks
321
Iqtiboslar
76
Asarlar
127
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
03581005010015020020172018201920202021202220232024202520262017: Nashrlar 3, Iqtiboslar 32018: Nashrlar 10, Iqtiboslar 52019: Nashrlar 5, Iqtiboslar 72020: Nashrlar 9, Iqtiboslar 102021: Nashrlar 7, Iqtiboslar 42022: Nashrlar 4, Iqtiboslar 212023: Nashrlar 3, Iqtiboslar 262024: Nashrlar 3, Iqtiboslar 412025: Nashrlar 1, Iqtiboslar 642026: Nashrlar 0, Iqtiboslar 124

Iqtibos tarixi

05010015020020172018201920202021202220232024202520262017: Iqtiboslar 32018: Iqtiboslar 52019: Iqtiboslar 72020: Iqtiboslar 102021: Iqtiboslar 42022: Iqtiboslar 212023: Iqtiboslar 262024: Iqtiboslar 412025: Iqtiboslar 642026: Iqtiboslar 124

Nashr tarixi

03581020172018201920202021202220232024202520262017: Nashrlar 32018: Nashrlar 102019: Nashrlar 52020: Nashrlar 92021: Nashrlar 72022: Nashrlar 42023: Nashrlar 32024: Nashrlar 32025: Nashrlar 12026: Nashrlar 0

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

03581020172018201920202021202220232024202520262017: h-indeks 32018: h-indeks 32019: h-indeks 32020: h-indeks 32021: h-indeks 32022: h-indeks 32023: h-indeks 42024: h-indeks 42025: h-indeks 52026: h-indeks 7

Eng koʻp iqtibos qilingan asarlar

  1. The Nairobi Declaration—Reducing the burden of dementia in low‐ and middle‐income countries (LMICs): Declaration of the 2022 Symposium on Dementia and Brain Aging in LMICs20231 iqtibos
  2. Potential of chemo-immunotherapy and radioimmunotherapy in relapsed primary central nervous system (CNS) lymphoma20070 iqtibos
  3. POSTER: CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management20230 iqtibos
  4. POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial20230 iqtibos
  5. Burnout among GU oncologists and associated factors: BUCARE survey.20240 iqtibos
  6. Response to “Scientific Concerns About Recent Fluid-Structure Interaction Models of the Aqueous Humor Outflow Pathway”20250 iqtibos